Association between remnant cholesterol and metabolic dysfunction-associated steatotic liver disease in the elderly

被引:1
作者
Lan, Yanqi [1 ]
Guo, Zhinan [1 ]
Dai, Junsheng [2 ]
Chen, Kailin [2 ]
Chen, Youlan [1 ]
机构
[1] Xiamen Ctr Dis Control & Prevent, 681-685 Shengguang Rd, Xiamen 361000, Fujian, Peoples R China
[2] Xiamen Municipal Hlth Commiss, Xiamen, Fujian, Peoples R China
关键词
Steatotic liver disease; Prevalence; Older; Remnant cholesterol; VISCERAL FAT; RISK-FACTORS; INFLAMMATION;
D O I
10.1016/j.dld.2024.03.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Whether maintaining optimal remnant cholesterol (RC) levels later in life may improve metabolic dysfunction-associated steatotic liver disease (MASLD) outcomes remained ambiguous. This study aimed to investigate the relationship between RC and MASLD in the elderly Chinese population. Methods: A total of 131,868 subjects aged >= 65 years were included in this study. The association of RC with MASLD, and severity of MASLD was analyzed by logistic regression. In addition, stratified analysis was conducted to test the potential interaction. Results: MASLD prevalence and RC concentration decreased with age. After adjustment for possible confounders, the odds ratio of MASLD at the highest quartile of RC compared to the lowest quartile was 1.587(95% CI: 1.524-1.652), and this effect remained in MASLD with liver fibrosis. Stratified analysis showed a more prominent effect on the MASLD in males, those aged 65-69 years, those without central obesity, those with diabetes, and normal level of total cholesterol, low-density lipoprotein cholesterol ( P for interaction < 0.05). Conclusions: In the elderly subset of the Chinese population, higher RC levels achieved a significant risk effect against MASLD. More RC monitoring should be given to older for the prevention and intervention of MASLD. (c) 2024 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1557 / 1564
页数:8
相关论文
共 40 条
[1]   NAFLD in the Elderly [J].
Alqahtani, Saleh A. ;
Schattenberg, Joern M. .
CLINICAL INTERVENTIONS IN AGING, 2021, 16 :1633-1649
[2]   Why visceral fat is bad: Mechanisms of the metabolic syndrome [J].
Bergman, Richard N. ;
Kim, Stella P. ;
Catalano, Karyn J. ;
Hsu, Isabel R. ;
Chiu, Jenny D. ;
Kabir, Morvarid ;
Hucking, Katrin ;
Ader, Marilyn .
OBESITY, 2006, 14 :16S-19S
[3]   The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes [J].
Cao, Ye-Xuan ;
Zhang, Hui-Wen ;
Jin, Jing-Lu ;
Liu, Hui-Hui ;
Zhang, Yan ;
Gao, Ying ;
Guo, Yuan-Lin ;
Wu, Na-Qiong ;
Hua, Qi ;
Li, Yan-Fang ;
Li, Xiao-Lin ;
Xu, Rui-Xia ;
Cui, Chuan-Jue ;
Liu, Geng ;
Dong, Qian ;
Sun, Jing ;
Zhu, Cheng-Gang ;
Li, Jian-Jun .
CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
[4]   Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies [J].
Chan, Kai En ;
Ong, Elden Yen Hng ;
Chung, Charlotte Hui ;
Ong, Christen En Ya ;
Koh, Benjamin ;
Tan, Darren Jun Hao ;
Lim, Wen Hui ;
Yong, Jie Ning ;
Xiao, Jieling ;
Wong, Zhen Yu ;
Syn, Nicholas ;
Kaewdech, Apichat ;
Teng, Margaret ;
Wang, Jiong-Wei ;
Chew, Nicholas ;
Young, Dan Yock ;
Know, Alfred ;
Siddiqui, Mohammad Shadab ;
Huang, Daniel Q. ;
Tamaki, Nobuharu ;
Wong, Vincent Wai-Sun ;
Mantzoros, Christos S. ;
Sanyal, Arun ;
Noureddin, Mazen ;
Ng, Cheng Han ;
Muthiah, Mark .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (03) :488-498
[5]   Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease [J].
Chen, Jingfei ;
Su, Yingjie ;
Su, Xin ;
Luo, Fei .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 201
[6]   Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease [J].
Cheng, Yiping ;
Zhang, Qiang ;
Li, Haizhen ;
Zhou, Guangshuai ;
Shi, Ping ;
Zhang, Xu ;
Guan, Liying ;
Yan, Fang ;
Xu, Chao .
FRONTIERS IN ENDOCRINOLOGY, 2023, 14
[7]   Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents [J].
Chin, Justin ;
Mori, Trevor A. ;
Adams, Leon A. ;
Beilin, Lawrence J. ;
Huang, Rae-Chi ;
Olynyk, John K. ;
Ayonrinde, Oyekoya T. .
JHEP REPORTS, 2020, 2 (06)
[8]  
China NhafpcotPsRo, 2017, The national essential public health service specification
[9]   Metabolic dysfunction-associated steatotic liver disease in older adults is associated with frailty and social disadvantage [J].
Clayton-Chubb, Daniel ;
Kemp, William W. ;
Majeed, Ammar ;
Lubel, John S. ;
Woods, Robyn L. ;
Tran, Cammie ;
Ryan, Joanne ;
Hodge, Alexander ;
Schneider, Hans G. ;
Mcneil, John J. ;
Roberts, Stuart K. .
LIVER INTERNATIONAL, 2024, 44 (01) :39-51
[10]   Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis [J].
DeFilippis, Andrew Paul ;
Blaha, Michael J. ;
Martin, Seth S. ;
Reed, Robert M. ;
Jones, Steven R. ;
Nasir, Khurram ;
Blumenthal, Roger S. ;
Budoff, Matthew J. .
ATHEROSCLEROSIS, 2013, 227 (02) :429-436